Aurora Cannabis Inc.
ACB
3.72 EUR
1 day: N/A
The alert is saved directly without jumping back to the homepage.
Price alerts for ACB
Please log in to view and save price alerts.
Finanzen
Company info
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
Aktuelle News
-
Aurora Cannabis Reiterates Opposition to Curaleaf's Takeover Offer
Vorschau anzeigen
Aurora Cannabis (ACB.TO) was last seen down 2.8% in after-hours Nasdaq trade after the company on W
-
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
Vorschau anzeigen
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, today reconfirms that the Board of Directors (the "Board"), on the unanimous recommendation of a special committee of independent directors (the "Special Committee"), unanimously recommends that shareholders REJECT the hostile offer by Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) for all of the issued and outstanding common shares of the Compan
-
Surprised By Aurora Cannabis’s Slide? What Investors Missed
Vorschau anzeigen
If you had looked at Aurora Cannabis on 13 October 2025 and hesitated, it might feel like you simply dodged a talking point rather than made a call. Holding Aurora Cannabis over the past year would have meant a 20.5% loss, including dividends. That result now sits beside new figures, with Q1 2027 revenue at CA$67.554 million and a smaller loss than Q1 2026. The open question is which early assumptions about regulation, competition, or profitability deserved harder scrutiny at the start. The...
-
BAT Could Decide Who Wins the Fight for Aurora Cannabis
Vorschau anzeigen
A BAT-backed rival is circling Aurora, setting up a potential bidding war with Curaleaf. But Organigram may need a cash injection from its tobacco giant backer to make a serious offer.
-
Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher
Vorschau anzeigen
Curaleaf looks eager to buy Aurora Cannabis, and that's helped to drive its value up.